These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dialysis encephalopathy in Kuala Lumpur. Abu Bakar Suleiman, Rejab SM, Khoo HE. Med J Malaysia; 1986 Mar; 41(1):12-8. PubMed ID: 3796341 [No Abstract] [Full Text] [Related]
3. [Current concepts of the role of aluminum in chronic kidney failure patients]. Gruev I, Belovezhdov N. Vutr Boles; 1983 Mar; 22(2):1-4. PubMed ID: 6362201 [No Abstract] [Full Text] [Related]
4. Role of desferrioxamine in the treatment of dialysis encephalopathy. Ackrill P, Ralston AJ, Day JP. Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985 [No Abstract] [Full Text] [Related]
5. [Aluminum and dialysis]. Rosenlöf K, Honkanen E. Duodecim; 1991 Feb; 107(11):898-900. PubMed ID: 1364734 [No Abstract] [Full Text] [Related]
9. [Progressive dialytic encephalopathy]. Rabey JM, Blum M, Vardi J, Aviram A, Moriel EZ, Streifler M. Harefuah; 1980 Mar 02; 98(5):205-7. PubMed ID: 7409633 [No Abstract] [Full Text] [Related]
10. A new approach to the early detection of dialysis encephalopathy. Ackrill P, Barron J, Whiteley S, Horn AC, Ralston AJ. Proc Eur Dial Transplant Assoc; 1979 Mar 02; 16():659-60. PubMed ID: 549004 [No Abstract] [Full Text] [Related]
11. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM. Arch Intern Med; 1986 Oct 02; 146(10):2063-4. PubMed ID: 3767553 [Abstract] [Full Text] [Related]